"Inauguré en 1995, l’Hôpital privé Claude Galien, établissement du groupe Ramsay Santé, est le fruit du regroupement de plusieurs établissements. En résulte une structure médicale de pointe dans de nombreux domaines tels que la chirurgie générale et orthopédique, la cardiologie, l’hémodialyse... Implanté dans la commune de Quincy-sous-Sénart, à 25 km de Paris, l’Hôpital privé Claude Galien dispose de 289 lits et places pour vous accueillir."

During the past decade, Hôpital Privé Claude Galien conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Privé Claude Galien" #1 sponsor was "Ramsay Générale de Santé" with 5 trials, followed by "GERCOR - Multidisciplinary Oncology Cooperative Group" with 4 trials sponsored, "European Cardiovascular Research Center" with 2 trials sponsored, "French Society for Intensive Care" with 2 trials sponsored and "Aarhus University Hospital Skejby" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Privé Claude Galien" #1 collaborator was "European Clinical Trial Experts Network" with 5 trials as a collaborator, "Boston Scientific; Pr Olivier Varenne" with 1 trials as a collaborator, "CHU Nantes" with 1 trials as a collaborator, "Cardiovascular European Research Center (CERC)" with 1 trials as a collaborator and "Medis Medical Imaging Systems" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Privé Claude Galien" are "Acute Coronary Syndrome" (2 trials), "Coronary Artery Disease" (2 trials), "Dialysis" (2 trials), "Intensive Care Unit Syndrome" (2 trials) and "Pancreatic Cancer" (2 trials). Many other conditions were trialed in "Hôpital Privé Claude Galien" in a lesser frequency.

Most popular intervention types in "Hôpital Privé Claude Galien" are "Device" (8 trials), "Other" (8 trials), "Procedure" (8 trials), "Drug" (5 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "fluorouracil" (3 trials), "gemcitabine hydrochloride" (2 trials), "leucovorin calcium" (2 trials), "radiation therapy" (2 trials) and "1 year follow-up to assess psychiatric morbidity" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Privé Claude Galien" are 29 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Privé Claude Galien". 2 are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Hôpital Privé Claude Galien, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Privé Claude Galien, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 9 trials that are defined as “Not Applicable".